Comparison between Aristo Bio-Tech IPO and SVS Ventures IPO.
Aristo Bio-Tech IPO is a SME Fixed Price IPO proposed to list at NSE SME while SVS Ventures IPO is a SME Fixed Price proposed to list at BSE SME.
| Aristo Bio-Tech IPO | SVS Ventures IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | First Overseas Capital Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Svcm Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aristo Bio-Tech IPO is up to ₹12.40 Cr whereas the issue size of the SVS Ventures IPO is up to ₹10.68 Cr. The final issue price of Aristo Bio-Tech IPO is ₹72.00 per share and of SVS Ventures IPO is ₹20.00 per share.
| Aristo Bio-Tech IPO | SVS Ventures IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹72.00 per share | ₹20.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 6000 shares |
| Fresh Issue Size | 17,21,600 shares | 53,40,000 shares |
| Fresh Issue Size (Amount) | up to ₹12.40 Cr | up to ₹10.68 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,21,600 shares | 53,40,000 shares |
| Issue Size Total (Amount) | up to ₹12.40 Cr | up to ₹10.68 Cr |
Aristo Bio-Tech IPO opens on Jan 16, 2023, while SVS Ventures IPO opens on Dec 30, 2022. The closing date of Aristo Bio-Tech IPO and SVS Ventures IPO is Jan 19, 2023, and Jan 04, 2023, respectively.
| Aristo Bio-Tech IPO | SVS Ventures IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 16, 2023 | Dec 30, 2022 |
| Issue Close | Jan 19, 2023 | Jan 04, 2023 |
| Basis Of Allotment (Tentative) | Jan 24, 2023 | Jan 09, 2023 |
| Initiation of Refunds (Tentative) | Jan 25, 2023 | Jan 10, 2023 |
| Credit of Share (Tentative) | Jan 27, 2023 | Jan 11, 2023 |
| Listing date (Tentative) | Jan 30, 2023 | Jan 12, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Aristo Bio-Tech IPO P/E ratio is 9.46, as compared to SVS Ventures IPO P/E ratio of 75.
| Aristo Bio-Tech IPO | SVS Ventures IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 90.49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.37 | 66.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.46 | 75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹49.02 Cr. | ₹42.70 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 29.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 35.64 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 5.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.93 | ₹10.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10 | 69.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aristo Bio-Tech IPO Retail Individual Investors (RII) are offered 8,60,800 shares while in SVS Ventures IPO retail investors are offered 8,60,800 shares. Qualified Institutional Buyers (QIB) are offered in Aristo Bio-Tech IPO and in SVS Ventures IPO.
| Aristo Bio-Tech IPO | SVS Ventures IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 91,200 shares | 2,82,000 shares |
| QIB | ||
| NII | 8,60,800 shares | 26,70,000 shares |
| RII | 8,60,800 shares | 26,70,000 shares |
| Employee | ||
| Others | ||
| Total | 17,21,600 shares | 53,40,000 shares |
Aristo Bio-Tech IPO subscribed 217.72x in total, whereas SVS Ventures IPO subscribed 1.27x.
| Aristo Bio-Tech IPO | SVS Ventures IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 285.84x | 0.53x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 149.59x | 2.01x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 217.72x | 1.27x |
